Hydroxychloroquine for chronic myeloid leukemia: complete cure on the horizon?

Mukhopadhyay, A., Helgason, G. V. , Karvela, M. and Holyoake, T. L. (2011) Hydroxychloroquine for chronic myeloid leukemia: complete cure on the horizon? Expert Review of Hematology, 4(4), pp. 369-371. (doi: 10.1586/ehm.11.34)

[img]
Preview
Text
54792.pdf

55kB

Publisher's URL: http://dx.doi.org/10.1586/ehm.11.34

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Holyoake, Professor Tessa and Mukhopadhyay, Dr Arunima and Helgason, Dr Vignir and Karvela, Miss Maria
Authors: Mukhopadhyay, A., Helgason, G. V., Karvela, M., and Holyoake, T. L.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Expert Review of Hematology
Publisher:Expert Reviews Ltd.
ISSN:1747-4086
ISSN (Online):1747-4094
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
439231Is Bcr-Able expression relevant for the survival of cancer stem cells in chronic myeloid leukaemiaTessa HolyoakeMedical Research Council (MRC)G0600782Institute of Cancer Sciences
503111A randomised Phase II trial of Imatinib (IM) versus hydroxychloroquine (HCQ) with IM for patients with chronic myeloid leukaemia (CML) in cytogenic response (CyR)- CHOICESTessa HolyoakeMedical Research Council (MRC)G0900882Institute of Cancer Sciences